Audit 351270

FY End
2024-06-30
Total Expended
$2.67M
Findings
0
Programs
5
Organization: Aspirus, Inc. (WI)
Year: 2024 Accepted: 2025-03-31
Auditor: Wipfli LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
21.027 Coronavirus State and Local Fiscal Recovery Funds $1.38M Yes 0
93.399 Cancer Control $448,266 - 0
93.155 Rural Health Research Centers $249,836 - 0
32.006 Covid-19 Telehealth Program $153,263 - 0
93.301 Small Rural Hospital Improvement Grant Program $12,444 - 0

Contacts

Name Title Type
CXANMMKWPE85 Jerry Yang Auditee
7158472526 Josh Boyle Auditor
No contacts on file

Notes to SEFA

Title: Note 1: Basis of Presentation Accounting Policies: Note 2: Summary of Significant Accounting Policies Expenditures on the Schedule are reported on the accrual basis of accounting and are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: Note 3: Indirect Costs Aspirus, Inc. and Subsidiaries has not elected to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (the “Schedule”) includes the federal award activity of Aspirus, Inc. and Subsidiaries under programs of the federal government for the year ended June 30, 2024. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Aspirus, Inc. and Subsidiaries, it is not intended to and does not present the financial position, statement of operations, changes in net assets or cash flows of Aspirus, Inc. and Subsidiaries.
Title: Note 4: Subrecipients Accounting Policies: Note 2: Summary of Significant Accounting Policies Expenditures on the Schedule are reported on the accrual basis of accounting and are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: Note 3: Indirect Costs Aspirus, Inc. and Subsidiaries has not elected to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance. Aspirus, Inc. and Subsidiaries does not have subrecipients of its federal awards.